Several Berkeley Lab scientists will present talks at the 72nd annual meeting of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society, to be held February 15 through 19 in Austin, Texas. Among them are four representing the Biosciences Area: Mary Maxon, Blake Simmons, Trent Northen, and Susannah Tringe.
FY19 Biosciences LDRD Information
The FY19 Laboratory Directed Research and Development (LDRD) Program has been announced by Director Witherell and the Call for Proposals (CFP) has been released. This schedule includes Biosciences Area due dates and activities; any changes and updates will be posted there.
Screening for Disease or Toxins in a Drop of Blood
A Berkeley Lab spin-out, Newomics is creating blood-based assays for diabetes diagnosis and management, and for the monitoring of environmental toxins, among other health care applications. The core technology, a multi-nozzle emitter array (MEA) for mass spectrometry, was developed by Newomics founder and president Daojing Wang, a guest scientist in Biological Systems and Engineering (BSE), while he was in the Lab’s Life Sciences Division (now part of the Biosciences Area). Collaborators on the emitter technology included Pan Mao, formerly in Life Sciences, and Peidong Yang in the Materials Sciences Division. Read more in the Berkeley Lab News Center.
Congratulations to Biosciences Area Director’s Award Recipients
Several Biosciences Area personnel are among the 2017 Berkeley Lab Director’s Awards honorees. This annual program recognizes outstanding contributions by employees to all facets of Lab activities. A ceremony honoring all of the 2017 recipients will be held on November 30 in the Building 50 Auditorium.
Maxon Named to Governor’s Advisory Committee on Precision Medicine
Mary Maxon, Associate Laboratory Director for Biosciences, is one of 14 people appointed by California Governor Jerry Brown to the Governor’s Advisory Committee on Precision Medicine. In April 2015, Governor Brown declared his interest in this area by announcing the California Initiative to Advance Precision Medicine (CIAPM), a first-in-the-nation, state-level effort to fund focused precision medicine projects to improve care and treatment for specific diseases. Precision medicine aims to use advanced computing and technology to better understand, treat and prevent disease. Maxon and her fellow committee members will advise the Governor’s Office on many aspects of policy issues relating to precision medicine, including data sharing and privacy within and across technology platforms and tools. Read more about the topics to be considered by the advisory committee and CIAPM in the Governor’s Office press release.
- « Previous Page
- Next Page »
Was this page useful?